
Consider buying Hims & Hers Health (HIMS), which is viewed as undervalued after a significant drop despite a strong Q3 report and a new share buyback program. Fundamentally strong companies like CorMedix (CRMD) and Zeta Global (ZETA) are also presented as buying opportunities after falling sharply despite recent outstanding results. For leveraged exposure to Bitcoin, MicroStrategy (MSTR) is trading at a discount to the value of its crypto holdings and is showing relative strength. The current "extreme fear" in the crypto market may signal a long-term buying opportunity for contrarian investors. The core strategy is to capitalize on market irrationality by acquiring sound companies that have been unfairly punished in the recent sell-off.

By @BeatTheDenominator